Karessa Pharma Holding AB announces today that a patent application for Vardenafil buccal film has been submitted to the European Patent Office
On the 20th of December 2017, Karessa submitted an application to the European Patent Office concerning the use and formulation of buccal film with Vardenafil.Karessa develops effective pharmaceuticals based on our patented buccal film and proven pharmaceutical substances in the therapeutic area of erectile dysfunction. As a result of this work, Karessa has now been able to submit a patent application for the use and formulation of the buccal film with Vardenafil. The patent application for the buccal film ("Film patent") was submitted in 2005 and the patent application has so far been